| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $159.6M | -10.0% |
| Cost of Revenue | $95.5M | -16.5% |
| Gross Profit | $64.2M | +2.0% |
| R&D Expense | $32.9M | -16.4% |
| SG&A Expense | $26.4M | +1.6% |
| Operating Income | -$28.0M | +60.3% |
| Interest Expense | $9.0M | +54.4% |
| Pre-tax Income | -$37.0M | +51.5% |
| Income Tax | $1.5M | +183.5% |
| Net Income | -$38.5M | +48.2% |
| EPS (Basic) | -$1.34 | +49.4% |
| EPS (Diluted) | -$1.34 | +49.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $40.3M | -0.3% |
| Inventory | $27.5M | -34.5% |
| Current Assets | $90.7M | -33.6% |
| Total Assets | $137.1M | -21.1% |
| Current Liabilities | $137.4M | +1.1% |
| Long-term Debt | $66.4M | -1.9% |
| Total Liabilities | $173.1M | -2.2% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.7M | -4.9% |
| Capital Expenditures | $440K | -93.1% |
| Investing Cash Flow | -$6.4M | +46.5% |
| Financing Cash Flow | -$1.4M | -103.2% |
| Free Cash Flow | -$16.1M | +24.5% |
| -$35.9M |
| -1010.5% |